Pengaruh Sudut Keruncingan Dan Diameter Finial Franklin Terhadap Distribusi Medan Listrik Dan Tingkat Tegangan Tembus

Penangkap petir merupakan bagian utama dari sistem penangkal petir eksternal. Finial atau penangkap petir berupa konduktor batang tegak merupakan finial yang memiliki konstruksi berupa sisi ujung finialnya secara umum berbentuk metal yang runcing sebagai pengumpul muatan listrik statis. Parameter utama yang menentukan baik buruknya kinerja finial Franklin tersebut dilihat dari level tegangan tembus (setelah korona) yang terjadi. Level tegangan tembus dipengaruhi oleh distribusi medan listrik, sedangkan distribusi medan listrik sendiri dipengaruhi oleh bentuk geometris elektroda. Pada finial Franklin, faktor keruncingan sangat menentukan distribusi medan listrik yang terjadi. Faktor keruncingan yang dimaksud adalah sudut keruncingan dan diameter finial. Pada penelitian penelitian ini dilakukan pengujian finial Franklin dengan variasi sudut keruncingan untuk setiap diameter finial Franklin terhadap tegangan korona dan tembus. Pengujian tegangan korona dan tembus tersebut menggunakan tegangan tinggi searah polaritas negatif dengan mengatur jarak sela elektroda. Selanjutnya dilakukan penggambaran distribusi medan listrik dan perhitungan efisiensi medan listrik setiap objek uji secara eksperimen menggunakan metode kertas konduktif dengan sumber DC tegangan tendah

Kinetic modelling of the methanol synthesis from CO₂ and H₂ over a CuO/CeO₂/ZrO₂ catalyst:The role of CO₂ and CO hydrogenation

This work addresses the kinetics of the CO2 hydrogenation to methanol over a Cu/CeO2/ZrO2 catalyst studied using single-site, dual-sites and three adsorption sites kinetic models. Physicochemical constraints and statistical indicators are used as tool for model discrimination. The best performing model is used to elucidate the reaction mechanism and the relative roles of the Cu-sites and oxygen vacancies. The results show that the dissociative adsorption of H2 occurs on the Cu0 sites, while CO2 is attracted to the oxygen vacancies created by the CeO2-ZrO2 solid solution. Then, the adsorbed H interacts preferentially with the carbon atom, favouring the so-called “formate” route. The CO formed via the r-WGS reaction could either desorb to the gas phase or react via hydrogenation to methanol. Analysis of the relative contributions of the CO2 and CO hydrogenation (i.e. direct and indirect pathways, respectively) to the methanol synthesis reveals that the latter is in fact preferential at high temperatures (i.e. about 100% of methanol is produced from CO at 260 ⁰C and 30 bar), and it shows an optimum vs the H2:CO2 ratio (c.a. 7 at 200 ⁰C and 30 bar), which corresponds to the saturation of the Cu0 sites with H2. Thus, this work provides an essential tool (i.e., kinetic model) for the design of reactors and processes based on novel catalysts, and importantly, it offers a deeper understanding of the reaction mechanism as basis for further catalyst development.</p

Pengaruh Sudut Keruncingan Dan Diameter Finial Franklin Terhadap Distribusi Medan Listrik dan Tingkat Tegangan Tembus

Penangkap petir merupakan bagian utama dari sistem penangkal petir eksternal. Finial atau penangkap petir berupa konduktor batang tegak merupakan finial yang memiliki konstruksi berupa sisi ujung finialnya secara umum berbentuk metal yang runcing sebagai pengumpul muatan listrik statis. Parameter utama yang menentukan baik buruknya kinerja finial Franklin tersebut dilihat dari level tegangan tembus (setelah korona) yang terjadi. Level tegangan tembus dipengaruhi oleh distribusi medan listrik, sedangkan distribusi medan listrik sendiri dipengaruhi oleh bentuk geometris elektroda. Pada finial Franklin, faktor keruncingan sangat menentukan distribusi medan listrik yang terjadi. Faktor keruncingan yang dimaksud adalah sudut keruncingan dan diameter finial. Pada penelitian penelitian ini dilakukan pengujian finial Franklin dengan variasi sudut keruncingan untuk setiap diameter finial Franklin terhadap tegangan korona dan tembus. Pengujian tegangan korona dan tembus tersebut menggunakan tegangan tinggi searah polaritas negatif dengan mengatur jarak sela elektroda. Selanjutnya dilakukan penggambaran distribusi medan listrik dan perhitungan efisiensi medan listrik setiap objek uji secara eksperimen menggunakan metode kertas konduktif dengan sumber DC tegangan tendah

Kinetic modelling of the methanol synthesis from CO2 and H2 over a CuO/CeO2/ZrO2 catalyst: The role of CO2 and CO hydrogenation

This work addresses the kinetics of the CO2 hydrogenation to methanol over a Cu/CeO2/ZrO2 catalyst studied using single-site, dual-sites and three adsorption sites kinetic models. Physicochemical constraints and statistical indicators are used as tool for model discrimination. The best performing model is used to elucidate the reaction mechanism and the relative roles of the Cu-sites and oxygen vacancies. The results show that the dissociative adsorption of H2 occurs on the Cu0 sites, while CO2 is attracted to the oxygen vacancies created by the CeO2-ZrO2 solid solution. Then, the adsorbed H interacts preferentially with the carbon atom, favouring the so-called “formate” route. The CO formed via the r-WGS reaction could either desorb to the gas phase or react via hydrogenation to methanol. Analysis of the relative contributions of the CO2 and CO hydrogenation (i.e. direct and indirect pathways, respectively) to the methanol synthesis reveals that the latter is in fact preferential at high temperatures (i.e. about 100% of methanol is produced from CO at 260 ⁰C and 30 bar), and it shows an optimum vs the H2:CO2 ratio (c.a. 7 at 200 ⁰C and 30 bar), which corresponds to the saturation of the Cu0 sites with H2. Thus, this work provides an essential tool (i.e., kinetic model) for the design of reactors and processes based on novel catalysts, and importantly, it offers a deeper understanding of the reaction mechanism as basis for further catalyst development

Jasmonic acid is required for tomato acclimation to multifactorial stress combination

As a result of global warming and climate change, the number and intensity of weather events such as droughts, heat waves, and floods are increasing, resulting in major losses in crop yield worldwide. Combined with the accumulation of different pollutants, this situation is leading to a gradual increase in the complexity of environmental factors affecting plants. We recently used the term ‘multifactorial stress combination’ (MFSC) to describe the impact of three or more stressors occurring simultaneously or sequentially on plants. Here, we show that a MFSC of six different abiotic stressors (high light, heat, nitrogen deficiency, paraquat, cadmium, and salinity) has a negative impact on the growth, photosystem II function, and photosynthetic activity of mature tomato plants. We further reveal a negative correlation between proline accumulation and the increasing number of stress factors combined, suggesting that proline could have an adverse effect on plants during MFSC. Our findings further indicate that alterations in hormonal levels and stomatal responses are stress/stress combination-dependent, and that a tomato mutant deficient in jasmonic acid accumulation is more sensitive to high light and its combinations with salinity and/or paraquat. Taken together, our study reveals that the effects of MFSC on tomato plants are broad, that photosynthesis and proline accumulation are especially vulnerable to MFSC, and that jasmonic acid is required for tomato acclimation to MFSCs involving high light, salinity and paraquat.Funding for open access charge: CRUE-Universitat Jaume

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Background: Additional safe and efficacious vaccines are needed to control the COVID-19 pandemic. We aimed to analyse the efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate. Methods: HERALD is a randomised, observer-blinded, placebo-controlled, phase 2b/3 clinical trial conducted in 47 centres in ten countries in Europe and Latin America. By use of an interactive web response system and stratification by country and age group (18–60 years and ≥61 years), adults with no history of virologically confirmed COVID-19 were randomly assigned (1:1) to receive intramuscularly either two 0·6 mL doses of CVnCoV containing 12 μg of mRNA or two 0·6 mL doses of 0·9% NaCl (placebo) on days 1 and 29. The primary efficacy endpoint was the occurrence of a first episode of virologically confirmed symptomatic COVID-19 of any severity and caused by any strain from 15 days after the second dose. For the primary endpoint, the trial was considered successful if the lower limit of the CI was greater than 30%. Key secondary endpoints were the occurrence of a first episode of virologically confirmed moderate-to-severe COVID-19, severe COVID-19, and COVID-19 of any severity by age group. Primary safety outcomes were solicited local and systemic adverse events within 7 days after each dose and unsolicited adverse events within 28 days after each dose in phase 2b participants, and serious adverse events and adverse events of special interest up to 1 year after the second dose in phase 2b and phase 3 participants. Here, we report data up to June 18, 2021. The study is registered at ClinicalTrials.gov, NCT04652102, and EudraCT, 2020–003998–22, and is ongoing. Findings: Between Dec 11, 2020, and April 12, 2021, 39 680 participants were enrolled and randomly assigned to receive either CVnCoV (n=19 846) or placebo (n=19 834), of whom 19 783 received at least one dose of CVnCoV and 19 746 received at least one dose of placebo. After a mean observation period of 48·2 days (SE 0·2), 83 cases of COVID-19 occurred in the CVnCoV group (n=12 851) in 1735·29 person-years and 145 cases occurred in the placebo group (n=12 211) in 1569·87 person-years, resulting in an overall vaccine efficacy against symptomatic COVID-19 of 48·2% (95·826% CI 31·0–61·4; p=0·016). Vaccine efficacy against moderate-to-severe COVID-19 was 70·7% (95% CI 42·5–86·1; CVnCoV 12 cases in 1735·29 person-years, placebo 37 cases in 1569·87 person-years). In participants aged 18–60 years, vaccine efficacy against symptomatic disease was 52·5% (95% CI 36·2–64·8; CVnCoV 71 cases in 1591·47 person-years, placebo, 136 cases in 1449·23 person-years). Too few cases occurred in participants aged 61 years or older (CVnCoV 12, placebo nine) to allow meaningful assessment of vaccine efficacy. Solicited adverse events, which were mostly systemic, were more common in CVnCoV recipients (1933 [96·5%] of 2003) than in placebo recipients (1344 [67·9%] of 1978), with 542 (27·1%) CVnCoV recipients and 61 (3·1%) placebo recipients reporting grade 3 solicited adverse events. The most frequently reported local reaction after any dose in the CVnCoV group was injection-site pain (1678 [83·6%] of 2007), with 22 grade 3 reactions, and the most frequently reported systematic reactions were fatigue (1603 [80·0%] of 2003) and headache (1541 [76·9%] of 2003). 82 (0·4%) of 19 783 CVnCoV recipients reported 100 serious adverse events and 66 (0·3%) of 19 746 placebo recipients reported 76 serious adverse events. Eight serious adverse events in five CVnCoV recipients and two serious adverse events in two placebo recipients were considered vaccination-related. None of the fatal serious adverse events reported (eight in the CVnCoV group and six in the placebo group) were considered to be related to study vaccination. Adverse events of special interest were reported for 38 (0·2%) participants in the CVnCoV group and 31 (0·2%) participants in the placebo group. These events were considered to be related to the trial vaccine for 14 (<0·1%) participants in the CVnCoV group and for five (<0·1%) participants in the placebo group. Interpretation: CVnCoV was efficacious in the prevention of COVID-19 of any severity and had an acceptable safety profile. Taking into account the changing environment, including the emergence of SARS-CoV-2 variants, and timelines for further development, the decision has been made to cease activities on the CVnCoV candidate and to focus efforts on the development of next-generation vaccine candidates. Funding: German Federal Ministry of Education and Research and CureVac

Probing the nature of the χc1(3872)\chi_{c1}(3872) state using radiative decays

International audienceThe radiative decays $\chi_{c1}(3872)\rightarrow\psi(2S)\gamma$ and $\chi_{c1}(3872)\rightarrow J/\psi\gamma$ are used to probe the~nature of the~$\chi_{c1}(3872)$ state using proton-proton collision data collected with the LHCb detector, corresponding to an~integrated luminosity of~9fb$^{-1}$. Using the~$B^+\rightarrow \chi_{c1}(3872)K^+$decay, the $\chi_{c1}(3872)\rightarrow \psi(2S)\gamma$ process is observed for the first time and the ratio of its partial width to that of the $\chi_{c1}(3872)\rightarrow J/\psi\gamma$ decay is measured to be $$\frac{\Gamma_{\chi_{c1}(3872)\rightarrow \psi(2S)\gamma}} {\Gamma_{\chi_{c1}(3872)\rightarrow J/\psi\gamma}} = 1.67 \pm 0.21 \pm 0.12 \pm0.04 ,$$ where the first uncertainty is statistical, the second systematic and the third is due to the uncertainties on the branching fractions of the $\psi(2S)$ and $J/\psi$ mesons. The measured ratio makes the interpretation of the $\chi_{c1}(3872)$ state as a~pure $D^0\bar{D}^{*0}+\bar{D}^0D^{*0}$ molecule questionable and strongly indicates a sizeable compact charmonium or tetraquark component within the $\chi_{c1}(3872)$ state

Probing the nature of the χc1(3872)\chi_{c1}(3872) state using radiative decays

International audienceThe radiative decays $\chi_{c1}(3872)\rightarrow\psi(2S)\gamma$ and $\chi_{c1}(3872)\rightarrow J/\psi\gamma$ are used to probe the~nature of the~$\chi_{c1}(3872)$ state using proton-proton collision data collected with the LHCb detector, corresponding to an~integrated luminosity of~9fb$^{-1}$. Using the~$B^+\rightarrow \chi_{c1}(3872)K^+$decay, the $\chi_{c1}(3872)\rightarrow \psi(2S)\gamma$ process is observed for the first time and the ratio of its partial width to that of the $\chi_{c1}(3872)\rightarrow J/\psi\gamma$ decay is measured to be $$\frac{\Gamma_{\chi_{c1}(3872)\rightarrow \psi(2S)\gamma}} {\Gamma_{\chi_{c1}(3872)\rightarrow J/\psi\gamma}} = 1.67 \pm 0.21 \pm 0.12 \pm0.04 ,$$ where the first uncertainty is statistical, the second systematic and the third is due to the uncertainties on the branching fractions of the $\psi(2S)$ and $J/\psi$ mesons. The measured ratio makes the interpretation of the $\chi_{c1}(3872)$ state as a~pure $D^0\bar{D}^{*0}+\bar{D}^0D^{*0}$ molecule questionable and strongly indicates a sizeable compact charmonium or tetraquark component within the $\chi_{c1}(3872)$ state

Study of the rare decay J ⁣/ψ→μ+μ−μ+μ−J\mskip -3mu/\mskip -2mu\psi \to \mu^+\mu^-\mu^+\mu^-

The rare electromagnetic $J\mskip -3mu/\mskip -2mu\psi \to \mu^+\mu^-\mu^+\mu^-$ decay is observed with a significance greatly exceeding the discovery threshold, using proton-proton collision data collected by the LHCb experiment during 2016--2018 at a center-of-mass energy of 13 TeV, corresponding to an integrated luminosity of $5.4\,\text{fb}^{-1}$. The rate of this decay is measured relative to that of the $J\mskip -3mu/\mskip -2mu\psi \to \mu^+\mu^-$ mode. Using the QED model for the four-muon decay in the efficiency estimation, its branching fraction is determined to be \begin{equation*} {\mathcal{B}}(J\mskip -3mu/\mskip -2mu\psi \to \mu^+\mu^-\mu^+\mu^-) = (1.13\pm0.10\pm0.05\pm0.01)\times 10^{-6}, \end{equation*} where the uncertainties are statistical, systematic and due to the uncertainty on the branching fraction of the $J\mskip -3mu/\mskip -2mu\psi \to \mu^+\mu^-$ decay.The rare electromagnetic $J/\psi \to \mu^+\mu^-\mu^+\mu^-$ decay is observed with a significance greatly exceeding the discovery threshold, using proton-proton collision data collected by the LHCb experiment during 2016-2018 at a center-of-mass energy of 13 TeV, corresponding to an integrated luminosity of $5.4\,\text{fb}^{-1}$. The rate of this decay is measured relative to that of the $J/\psi \to \mu^+\mu^-$ mode. Using the QED model for the four-muon decay in the efficiency estimation, its branching fraction is determined to be \begin{equation*} {\mathcal{B}}(J/\psi \to \mu^+\mu^-\mu^+\mu^-) = (1.13\pm0.10\pm0.05\pm0.01)\times 10^{-6}, \end{equation*} where the uncertainties are statistical, systematic and due to the uncertainty on the branching fraction of the $J/\psi \to \mu^+\mu^-$ decay